Skip to content
AnalystLens
Back to MRNAIncome Statement

Moderna, Inc. Gross Profit 2018-2026 | MRNA

Annual FY2018–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$1.08B

−39.3%YoY vs FY2024Source: 10-KFY2025

From $135.1M in FY2018 to $1.08B in FY2025: 8.0× in 7 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26−$566M−3244.4%Not reportedNot reportedNot reported
FY25$18M−74.6%$23M−81.7%$809M−40.0%$226M−0.4%
FY24$71M−93.4%$126M+132.6%$1.3B+428.8%$227M−87.9%
FY23$1.1B−78.8%−$387M−111.5%−$410M−118.1%$1.9B−40.6%
FY22$5.0B+189.5%$3.4B−6.5%$2.3B−46.7%$3.2B−49.4%
Share11%13%43%33%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date. Share: its typical part of the fiscal year.

Key Statistics

Trend DirectionDeclining
CAGR

+6.2%

FY2020
$795.0M
FY2025
$1.08B

5 years selected · on the chart

Gross Profit History

Year-over-year comparison from 10-K annual reports

  1. $1.08B
YoY changeLargest recent move+1894.2%in FY21Latest −39.3%

2 older moves run past ±150% (largest +1894.2%); point at, tap or drag across the bars to read one.

Gross Profit, period by period

PeriodValueChangeSource
FY2025$1.08B−39.3%10-K
FY2024$1.77B−17.8%10-K
FY2023$2.15B−84.4%10-K
FY2022$13.85B−12.7%10-K
FY2021$15.85B+1894.2%10-K
FY2020$795.0M+1225.0%10-K
FY2019$60.0M−55.6%10-K
FY2018$135.1M—10-K

What is gross profit?

Gross profit can be defined as revenue minus the cost of goods sold, representing the profit a company makes before deducting operating expenses.

What is Moderna, Inc.'s current gross profit?

Moderna, Inc. (MRNA) annual gross profit for 2025 was $1.08B, a 39.28% decline from 2024. Moderna, Inc. gross profit for the quarter ending March 31, 2026 was $-566.0M.

What was Moderna, Inc.'s gross profit in 2024?

Moderna, Inc. annual gross profit for 2024 was $1.77B, a 17.77% decline from 2023.

What was Moderna, Inc.'s gross profit in 2023?

Moderna, Inc. annual gross profit for 2023 was $2.15B, a 84.44% decline from 2022.

What is Moderna, Inc.'s 5-year gross profit CAGR?

Moderna, Inc. gross profit grew at a compound annual growth rate (CAGR) of 6.24% from FY2020 to FY2025, going from $795.0M to $1.08B over 5 years.

Company
Moderna, Inc.
Ticker
MRNA
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)